Treatment of multiple sclerosis with long acting glatiramer and adipose-derived stem cells
Methods of treating multiple sclerosis are provided, comprising parenterally administering glatiramer acetate in a sustained-release depot form, and administering adipose-derived stem cells into the central nervous system. According to some aspects the combined treatments provide synergistic effects...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English Hebrew |
Published |
01.06.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Methods of treating multiple sclerosis are provided, comprising parenterally administering glatiramer acetate in a sustained-release depot form, and administering adipose-derived stem cells into the central nervous system. According to some aspects the combined treatments provide synergistic effects. In particular the combined therapies offer benefits to progressive forms of multiple sclerosis. |
---|---|
Bibliography: | Application Number: IL20190270355 |